Headlines

Estimating Quality of Life Based on Cumulative Drug Toxicity in Colorectal Cancer

Estimating Quality of Life Based on Cumulative Drug Toxicity in Colorectal Cancer

Results of a study in which more than 100 patients with metastatic colorectal cancer completed EORTC-QLQ-C30 suggests an association between assessment of cumulative drug toxicities and predictions of quality of life for patients undergoing first-line chemotherapy for the disease.

Communication in Shared Decision-Making in Oncology

Communication in Shared Decision-Making in Oncology

Researchers investigated the effectiveness of different communication approaches used in shared decision-making with cancer patients.

Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers

Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers

The family and friends of a patient diagnosed with blood cancer are often eager to help but unsure how to go about it. This article offers 8 practical tips oncology nurses can share with caregivers.

Culturally Sensitive Navigation Bridges Some Care Gaps for Latino Adults With Advanced Cancer

Culturally Sensitive Navigation Bridges Some Care Gaps for Latino Adults With Advanced Cancer

Researchers explored the effectiveness of tailoring patient navigation programs to address cultural and language barriers for Latino adults with advanced cancer.

Nedaplatin vs Cisplatin for Malignancy-Induced MPE: Noninferior, Less Toxicity

Nedaplatin vs Cisplatin for Malignancy-Induced MPE: Noninferior, Less Toxicity

Researchers sought to determine if nedaplatin could effectively manage malignancy-induced MPE in patients with cancer with less toxicity than cisplatin.

Endocrine Society Released Guidelines for Managing Endocrine Disorders in Childhood Cancer Survivors

Endocrine Society Released Guidelines for Managing Endocrine Disorders in Childhood Cancer Survivors

Clinical guideline reviews the diagnosis and treatment of hypothalamic-pituitary and growth disorders that are often seen in survivors of childhood cancer.

Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT

Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT

An international multidisciplinary panel of experts in pediatric oncology and infectious diseases convened to develop recommendations for the prevention and treatment of C difficile infection in pediatric patients with cancer or who are undergoing HSCT.

Failure Rates for HPV Vaccine Higher in HIV-Positive Women, Girls

Failure Rates for HPV Vaccine Higher in HIV-Positive Women, Girls

Canadian investigators conducted a national observational study in which women and girls living with HIV underwent HPV vaccination.

American Association for Cancer Research Releases Its 2018 Annual Report

American Association for Cancer Research Releases Its 2018 Annual Report

In its 2018 annual report, the AACR highlights the advances, challenges, and needs of federally funded research on the prevention, detection, diagnosis, and treatment of cancer.

Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma

Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma

An updated network meta-analysis found that a triplet regimen consisting of lenalidomide and dexamethasone plus an immunotherapeutic agent had better efficacy in terms of NRR, TTP, PFS, and OS than other regimens.

Conference Coverage

Lung Cancer: What Nurse Navigators Need to Know in 2018

There have been many recent changes in lung cancer, including updated early detection possibilities and changes in diagnostic procedures, reporting, and treatment options. These are reviewed in a presentation at the 2018 ONA Navigation Summit.

Navigating Patients with Hematologic Malignancies

Patients with hematologic cancers often require a combination of inpatient and outpatient care. The oncology nurse navigator is an ideal care provider to help patients manage their care and transitions between care settings, according to a presentation at the 2018 ONA Navigation Summit.

Navigating the Benefits and Challenges of Immunotherapy

A review of immunotherapy — what they are, how they work, and what to watch for — was presented at the 2018 ONA Navigation Summit.

Difficult Conversations: The Role of Nurse Navigator

Suggestions for communication points that improve the experience of patients with cancer through nurse navigation were presented at the 2018 ONA Navigation Summit.

Navigating Patients With Gastrointestinal Cancer

The unique challenges that face both oncology nurse navigators specializing in gastrointestinal cancer and patients with these diseases are reviewed in a presentation at the 2018 ONA Navigation Summit.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs